Cavo, Michele
Alma Mater Studiorum Università di Bologna,
Italy
2025 Rank: 24603
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 484 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24603 | 22346 |
| Total Cites | 5173 | 6111 |
| H-index | 30 | 36 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 164 | 189 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 395 | 437 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2694 | 2905 |
| Ratio of Total Citations to Distinct Citing Papers | 1.92 | 2.10 |
| Self-Citation Percentage |
15.35%
|
|
Cavo, Michele
IRCCS Azienda Ospedaliero-Universitaria di Bologna,
Italy
2024 Rank: 23296
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 477 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23296 | 21655 |
| Total Cites | 4615 | 5554 |
| H-index | 31 | 35 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 148 | 168 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 422 | 474 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2449 | 2680 |
| Ratio of Total Citations to Distinct Citing Papers | 1.88 | 2.07 |
| Self-Citation Percentage |
16.91%
|
|
Cavo, Michele
IRCCS Azienda Ospedaliero-Universitaria di Bologna,
Italy
2023 Rank: 19321
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 458 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19321 | 17731 |
| Total Cites | 4483 | 5548 |
| H-index | 30 | 34 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 172 | 204 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 439 | 508 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2390 | 2663 |
| Ratio of Total Citations to Distinct Citing Papers | 1.88 | 2.08 |
| Self-Citation Percentage |
19.20%
|
|
Cavo, Michele
IRCCS Azienda Ospedaliero-Universitaria di Bologna,
Italy
2022 Rank: 14217
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 403 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14217 | 11546 |
| Total Cites | 4279 | 5395 |
| H-index | 31 | 35 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 7 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 222 | 260 |
| Number of Single+First+Last Authored Papers | 115 | 115 |
| Total Cites to Single+First+Last Authored Papers | 491 | 568 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2200 | 2480 |
| Ratio of Total Citations to Distinct Citing Papers | 1.95 | 2.18 |
| Self-Citation Percentage |
20.69%
|
|
Cavo, Michele
Alma Mater Studiorum Università di Bologna,
Italy
2021 Rank: 14567
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 371 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14567 | 13037 |
| Total Cites | 5710 | 7191 |
| H-index | 37 | 40 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 12 | 13 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 302 | 347 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 720 | 821 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2887 | 3255 |
| Ratio of Total Citations to Distinct Citing Papers | 1.98 | 2.21 |
| Self-Citation Percentage |
20.60%
|
|
Cavo, Michele
Alma Mater Studiorum Università di Bologna,
Italy
2020 Rank: 16377
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 382 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16377 | 14265 |
| Total Cites | 3638 | 4647 |
| H-index | 27 | 31 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 216 | 243 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 515 | 596 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1873 | 2108 |
| Ratio of Total Citations to Distinct Citing Papers | 1.94 | 2.20 |
| Self-Citation Percentage |
21.71%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.